- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
Dr Vasant Narasimhan elected a member of the US National Academy of Medicine
11 November 2015 • Author: Victoria White
The US National Academy of Medicine (NAM) recently announced the election of Dr Vasant “Vas” Narasimhan as a member of the Academy.
Dr Narasimhan is the only pharmaceutical industry representative on the 2015 list.
“I am honored to join the Academy and look forward to working with my fellow members and health policy makers on tackling the challenges facing patients and our health care system,” said Dr Narasimhan.
Global Head of Development at Novartis
Dr Narasimhan is Global Head of Development at Novartis where he oversees all functions and project teams related to new product development globally, most recently leading the approval of first in class molecules Entresto for heart failure and Cosentyx for psoriasis. Previously, he was Global Development Head at Novartis Vaccines where he oversaw the development and licensure of multiple first in class vaccines using novel cell and genetic technologies including Bexsero, Menveo, Flucelvax, Fluad, and multiple pandemic vaccines. Prior to joining Novartis, Dr Narasimhan worked on a range of public health initiatives focused on addressing global health inequities.
“Our newly elected members represent the brightest, most influential, and passionate people in health, science, and medicine in our nation and internationally,” said NAM President Dr Victor J. Dzau. “They are at the top of their fields and are committed to service. The expertise they bring to the organisation will help us respond to today’s most pressing health-related challenges and inform the future of health, science, and medicine. It is my privilege to welcome these distinguished individuals to the National Academy of Medicine.”
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd B&W Tek Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited CAPSUGEL NV Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) Eurofins BioPharma Product Testing EUROGENTEC F.P.S. Food and Pharma Systems Srl GE Analytical Instruments IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited MA Business Metrohm Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Ocean Optics Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Viavi Solutions, Inc Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics